These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Kokkorakis M; Muzurović E; Volčanšek Š; Chakhtoura M; Hill MA; Mikhailidis DP; Mantzoros CS Pharmacol Rev; 2024 May; 76(3):454-499. PubMed ID: 38697855 [TBL] [Abstract][Full Text] [Related]
55. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine. Hermanson JB; Tolba SA; Chrisler EA; Leone VA J Nutr Biochem; 2024 Nov; 133():109704. PubMed ID: 39029595 [TBL] [Abstract][Full Text] [Related]
56. Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes. Castera L; Garteiser P; Laouenan C; Vidal-Trécan T; Vallet-Pichard A; Manchon P; Paradis V; Czernichow S; Roulot D; Larger E; Pol S; Bedossa P; Correas JM; Valla D; Gautier JF; Van Beers BE; J Hepatol; 2024 Aug; 81(2):195-206. PubMed ID: 38548067 [TBL] [Abstract][Full Text] [Related]
57. Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease. Kocas-Kilicarslan ZN; Cetin Z; Faccioli LAP; Motomura T; Amirneni S; Diaz-Aragon R; Florentino RM; Sun Y; Pla-Palacin I; Xia M; Miedel MT; Kurihara T; Hu Z; Ostrowska A; Wang Z; Constantine R; Li A; Taylor DL; Behari J; Soto-Gutierrez A; Tafaleng EN Gastro Hep Adv; 2024; 3(1):67-77. PubMed ID: 38292457 [TBL] [Abstract][Full Text] [Related]
58. Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease. Li W; Yu L Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):355-369. PubMed ID: 38833340 [TBL] [Abstract][Full Text] [Related]
59. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Targher G; Byrne CD; Tilg H Gut; 2024 Mar; 73(4):691-702. PubMed ID: 38228377 [TBL] [Abstract][Full Text] [Related]
60. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study. Kouvari M; Valenzuela-Vallejo L; Guatibonza-Garcia V; Polyzos SA; Deng Y; Kokkorakis M; Agraz M; Mylonakis SC; Katsarou A; Verrastro O; Markakis G; Eslam M; Papatheodoridis G; George J; Mingrone G; Mantzoros CS Metabolism; 2023 Oct; 147():155666. PubMed ID: 37527759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]